Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 8 EP applications Micael Owald has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11702418

FACTOR VII FUSION POLYPEPTIDES

IPC classification:
C07K 14/745, C12N 15/62
Applicant:
Novo Nordisk Health Care AG
Agent:
Micael Owald, Novo Nordisk A/S
Status:
APPLICATION WITHDRAWN
EP13709227

FVIIA-STF COMPLEXES EXHIBITING EXOSITE-MEDIATED SUPER ACTIVITY

IPC classification:
A61K 38/48, C07K 14/705, C07K 14/745, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Multiple attorneys, Novo Nordisk A/S
Status:
APPLICATION WITHDRAWN
EP13777046

COAGULATION FACTOR VII POLYPEPTIDES

IPC classification:
A61K 38/48, A61K 47/48, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Micael Owald, Novo Nordisk A/S
Status:
APPLICATION WITHDRAWN
EP13776814

FACTOR VII CONJUGATES

IPC classification:
A61K 47/48, A61P 7/04, C12N 9/64, C12N 15/57
Applicant:
Novo Nordisk Health Care AG
Agent:
Witte, Weller & Partner Patentanwälte mbB
Agent:
Micael Owald, Novo Nordisk A/S
Status:
EXAMINATION IN PROGRESS
EP15174742

PROCESS FOR PROTEIN PRODUCTION

IPC classification:
C12M 3/06, C12N 5/00, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Micael Owald, Novo Nordisk A/S
Status:
EXAMINATION IN PROGRESS
EP14786841

COAGULATION FACTOR VII POLYPEPTIDES

IPC classification:
A61K 38/48, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Micael Owald, Novo Nordisk A/S
Status:
EXAMINATION REQUESTED
EP11764561

PROCESS FOR PROTEIN PRODUCTION

IPC classification:
C12M 3/06, C12N 5/00, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Amanda Louise Simons, J A Kemp
Agent:
Micael Owald, Novo Nordisk A/S
Status:
PATENT GRANTED
EP15705571

FACTOR VII CONJUGATES

IPC classification:
A61K 47/48, A61P 7/02
Applicant:
Novo Nordisk Health Care AG
Agent:
Witte, Weller & Partner Patentanwälte mbB
Agent:
Micael Owald, Novo Nordisk A/S
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature